---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-024676"
form_type: "8-K"
ticker: "TVRD"
cik: "0001346830"
company_name: "Tvardi Therapeutics, Inc."
filed_at: "2026-03-06T23:59:59+00:00"
generated_at: "2026-05-15T18:36:09.857871+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Tvardi Therapeutics announces June 9, 2026 annual meeting; sets proposal deadlines

## Summary
- Annual meeting of stockholders scheduled for June 9, 2026.
- Rule 14a-8 stockholder proposals for proxy inclusion must be received by March 16, 2026.
- Advance notice for director nominations and other business under bylaws due March 16, 2026.
- Universal proxy rule (Rule 14a-19) notices for director nominees due April 10, 2026.

## SEC filing metadata
- accession: 0001104659-26-024676
- form_type: 8-K
- ticker: TVRD
- cik: 0001346830
- company_name: Tvardi Therapeutics, Inc.
- filed_at: 2026-03-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1346830/000110465926024676/0001104659-26-024676-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1346830/000110465926024676/tm268178d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-024676
- JSON: https://secwatch.observer/filing/0001104659-26-024676.json
- Plain text: https://secwatch.observer/filing/0001104659-26-024676.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.